Still Hungry on Tirzepatide — and Not Sure Why?

The question you need to answer first: is this physical hunger or habit?

Before deciding anything, it helps to sit with one honest question: are you hungry, or are you used to being hungry at this time of day? This is not a criticism. Years of eating patterns leave strong cues (the 1pm desk lunch, the biscuit with tea, the after-dinner snack) and tirzepatide does not erase those associations overnight.

Physical hunger on tirzepatide tends to feel different from pre-treatment hunger. It is usually milder, comes on more slowly, and passes with a small amount of food. If what you are feeling is sharp, urgent or tied closely to a time of day or an emotional state, it is more likely to be habit-driven. That distinction matters because the response is different: physical hunger may point to a dietary gap (often protein), while habitual hunger responds better to a change in routine than a change in eating.

Our clinical team hears this question regularly, and the honest answer is that both types are real and both are manageable. The reasons hunger persists on tirzepatide often come down to this distinction, and naming it is the first step.

What tirzepatide actually does to appetite, and why it takes time

Tirzepatide works by activating both GIP and GLP-1 receptors, two gut-hormone pathways involved in appetite regulation and the feeling of fullness after a meal. It also slows gastric emptying, so food stays in the stomach longer. These effects are real, but they accumulate. At the starting dose of 2.5mg (the lowest strength, used for the first month) the hormonal signal is present but relatively modest. The appetite effects most people associate with this treatment tend to become more noticeable as the dose increases, typically in four-week steps guided by the prescriber.

This means asking why am I still hungry on tirzepatide in week two or three is a fair and expected question. It does not mean the medicine is not working. The relationship between tirzepatide and food changes throughout treatment, and what felt inadequate at 2.5mg often looks very different at higher doses.

The NHS explains how tirzepatide reduces appetite through these receptor mechanisms in its patient information for tirzepatide, which is a useful reference if you want a plain-language breakdown of the pharmacology: NHS tirzepatide guidance.

The dietary factors most likely to be keeping you hungry

When tirzepatide is working as expected and hunger is still present, dietary composition is usually the cause. Three factors come up most often.

Protein. Smaller portions mean less protein unless you prioritise it deliberately. Protein is the most satiating macronutrient, it triggers fullness hormones independently of tirzepatide's effects, and a low-protein meal leaves appetite signals unsatisfied regardless of its calorie count. Lean meat, fish, eggs, dairy, legumes and tofu all count. Aiming for protein to take up roughly a third of each smaller plate is a reasonable starting framework, though your prescriber or a dietitian can give you a target suited to your weight and activity level.

Ultra-processed foods. Foods engineered for palatability (high salt, fat and refined carbohydrate combinations) can override fullness signals. Some people find their appetite for these intensifies when overall eating is reduced. They digest quickly, so the stomach empties faster and the short-term fullness from tirzepatide's gastric-slowing effect is undermined. Swapping these out often reduces hunger more than changing portion size alone.

Hydration. Dehydration is frequently misread as hunger. GI side effects in early treatment can reduce fluid intake without people noticing. Drinking consistently across the day, rather than in large amounts at mealtimes, tends to help.

For a more detailed look at what to eat alongside treatment, the eating guidance for people on Mounjaro covers this in full. And if you want broader context on how food choices interact with tirzepatide over time, the tirzepatide and food page goes deeper.

When to talk to your prescriber about persistent hunger

Some hunger during tirzepatide treatment is normal and expected. Persistent hunger that does not ease over several weeks, or hunger that returns sharply after a period of suppression, is worth raising.

It may indicate that the current dose has reached its ceiling effect for you specifically, and that a dose review is appropriate. It might also point to something else: inadequate sleep (which raises ghrelin, the hunger hormone), high stress levels, or a medical factor unrelated to the treatment. If you are still working out what is driving your appetite, our guide to feeling hungry on tirzepatide walks through the most common causes and what you can do about each one. These are clinical questions, not ones to answer alone.

At nume, sorry, at nume, every repeat order includes a clinical review before the next supply is issued. That is the natural moment to raise ongoing hunger, and the prescriber can look at the full picture rather than a single symptom in isolation. If you are curious about whether tirzepatide is right for your situation, or you are still feeling hungry on Mounjaro and want a clinical view, a free consultation is where that conversation starts.

If hunger is accompanied by severe stomach pain, vomiting you cannot keep fluids through, or other worrying symptoms, seek medical attention promptly. The NHS England guidance on weight management injections sets out when to get urgent help during treatment.

Ready to talk through how treatment is going? Start your free consultation and a GPhC-registered prescriber will review your situation the same day.